Showing results (1971-1980 of 2,021) with videos related to

Sort By:
Pageof 203
Nature Communications|December 5, 2025
Taming harmful bursts and heat flux in high-confinement tokamak plasmasQ M Hu, H Q Wang, M Navarro, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancersD Bennett, M Wierdl, S Chakraborty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER StudyKomal L Jhaveri, Elgene Lim, Rinath Jeselsohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2026
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: Pooled analysis of phase 1 and phase 2 trialsS-D Hong, Y-S Wang, H-Y Zhao, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Physical Review Letters|December 19, 2025
β-Decay Half-Lives of Neutron-Rich Sulfur to Potassium: Evolution of the N=32 and 34 Subshell Closures below CalciumQ B Zeng, S Nishimura, V H Phong, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|April 30, 2022
[Analysis of clinical phenotype and genotype of Chinese children with disorders of sex development]H Lin, H Yang, J F Fu, et al.
Pageof 203